Watchlist Price Alert

Viking Therapeutics Inc. (VKTX)

NASDAQ: VKTX · Real-Time Price · USD

26.21

-0.75 (-2.78%)

At close: Jun 17, 2025, 2:52 PM

Viking Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	26.68M	55.52M	36.63M	26.37M	29.12M	8.38M	24.78M	8.99M	3.08M
Short-Term Investments	875.94M	306.56M	118.85M	175.73M	219.27M	267.26M	276.74M	11.59M	10.08M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	102K	139K	71K	109K	77K	157K	179K	269.61K	560.88K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.13M	2.52M	3.41M	7.81M	n/a	n/a	n/a	388.97K	824.27K
Total Current Assets	907.22M	367.23M	167.04M	210.53M	256.1M	283.5M	302.13M	21.85M	13.97M
Property-Plant & Equipment	1M	1.13M	1.42M	25K	321K	598K	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.1M	1.26M	1.49M	134K	398K	755K	179K	269.61K	560.88K
Total Assets	908.32M	368.49M	168.53M	210.66M	256.5M	284.26M	302.31M	22.12M	14.54M
Account Payables	9.81M	7.51M	8.53M	1.44M	3.99M	2.43M	959K	1.53M	1.2M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.28M	1.27M
Short-Term Debt	489K	n/a	304K	29K	330K	302K	n/a	3.45M	3.27M
Other Current Liabilities	17.11M	n/a	-304K	-29K	-330K	-302K	n/a	1.4M	731.05K
Total Current Liabilities	27.41M	19.14M	21.95M	8.78M	12.13M	6.78M	4.55M	8.66M	6.48M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	12K	n/a	16.31K
Total Long-Term Liabilities	630K	936K	1.26M	n/a	29K	360K	12K	4.98M	16.31K
Total Liabilities	28.04M	20.07M	23.21M	8.78M	12.16M	7.14M	4.56M	8.66M	6.49M
Total Debt	1.12M	1.26M	1.56M	29K	359K	662K	n/a	3.45M	3.27M
Common Stock	1K	1K	1K	1K	1K	1K	1K	358.00	208.00
Retained Earnings	-487.91M	-377.94M	-292.05M	-223.18M	-168.19M	-128.7M	-102.92M	-80.85M	-60.28M
Comprehensive Income	-788K	-389K	-1.1M	-549K	-54K	12K	-423K	-19.77K	-6.89K
Shareholders Equity	880.28M	348.42M	145.32M	201.88M	244.34M	277.12M	297.75M	13.46M	8.04M
Total Investments	875.94M	306.56M	118.85M	175.73M	219.27M	267.26M	276.74M	11.59M	10.08M